ATE326978T1 - Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung - Google Patents
Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlungInfo
- Publication number
- ATE326978T1 ATE326978T1 AT02759995T AT02759995T ATE326978T1 AT E326978 T1 ATE326978 T1 AT E326978T1 AT 02759995 T AT02759995 T AT 02759995T AT 02759995 T AT02759995 T AT 02759995T AT E326978 T1 ATE326978 T1 AT E326978T1
- Authority
- AT
- Austria
- Prior art keywords
- apoptosis
- medical treatment
- disorders
- mimic natural
- vesicles
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 210000003617 erythrocyte membrane Anatomy 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32381801P | 2001-09-18 | 2001-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326978T1 true ATE326978T1 (de) | 2006-06-15 |
Family
ID=23260849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02759995T ATE326978T1 (de) | 2001-09-18 | 2002-09-13 | Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060035809A1 (de) |
| EP (1) | EP1427428B1 (de) |
| AT (1) | ATE326978T1 (de) |
| AU (1) | AU2002325739A1 (de) |
| CA (1) | CA2460098A1 (de) |
| DE (1) | DE60211721T2 (de) |
| DK (1) | DK1427428T3 (de) |
| ES (1) | ES2268071T3 (de) |
| PT (1) | PT1427428E (de) |
| WO (1) | WO2003024419A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006007529A2 (en) * | 2004-07-01 | 2006-01-19 | University Of Pittsburgh Of The Commonwealth System For Higher Education | Immunosuppressive exosomes |
| WO2006059329A1 (en) * | 2004-12-01 | 2006-06-08 | Hadasit Medical Research Services & Development Limited | Platelet-derived microparticles for therapy |
| WO2006107107A1 (ja) * | 2005-04-01 | 2006-10-12 | Fumitaka Ohsuzu | リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法 |
| RU2372078C1 (ru) * | 2008-03-19 | 2009-11-10 | Михаил Владимирович Покровский | Способ коррекции эндотелиальной дисфункции препаратом фосфоглив лиофилизат при l-name индуцированном дефиците оксида азота |
| WO2009155069A1 (en) * | 2008-05-28 | 2009-12-23 | Allan Mishra | Compositions and methods for treating psychiatric and neurodegenerative disorders |
| WO2015069897A1 (en) * | 2013-11-07 | 2015-05-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Red blood cell membrane-derived microparticles and their use for the treatment of lung disease |
| KR101720851B1 (ko) * | 2015-01-29 | 2017-03-28 | 포항공과대학교 산학협력단 | 세포의 지질막에서 유래된 나노소포체 및 이의 용도 |
| EP4091622A1 (de) | 2016-08-16 | 2022-11-23 | Henry Ford Health System | Zusammensetzungen zur behandlung von chemotherapie-induzierten neuropathischen schmerzen |
| CN114591905B (zh) * | 2022-04-01 | 2022-09-02 | 北京大学口腔医学院 | 一种人红细胞制备凋亡囊泡的方法与应用 |
| WO2024080931A1 (en) * | 2022-10-11 | 2024-04-18 | National University Of Singapore | Anti-inflammatory red blood cell extracellular vesicles (rbcevs) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1078043A1 (de) * | 1998-05-11 | 2001-02-28 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | Neue apoptotische körper, diese enthaltente zellen aus monocyten, verfahren zür deren herstellung und deren verwendung als impstoffen |
-
2002
- 2002-09-13 AT AT02759995T patent/ATE326978T1/de not_active IP Right Cessation
- 2002-09-13 ES ES02759995T patent/ES2268071T3/es not_active Expired - Lifetime
- 2002-09-13 DK DK02759995T patent/DK1427428T3/da active
- 2002-09-13 PT PT02759995T patent/PT1427428E/pt unknown
- 2002-09-13 EP EP02759995A patent/EP1427428B1/de not_active Expired - Lifetime
- 2002-09-13 CA CA002460098A patent/CA2460098A1/en not_active Abandoned
- 2002-09-13 AU AU2002325739A patent/AU2002325739A1/en not_active Abandoned
- 2002-09-13 WO PCT/CA2002/001397 patent/WO2003024419A2/en not_active Ceased
- 2002-09-13 DE DE60211721T patent/DE60211721T2/de not_active Expired - Fee Related
- 2002-09-13 US US10/489,999 patent/US20060035809A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2268071T3 (es) | 2007-03-16 |
| US20060035809A1 (en) | 2006-02-16 |
| EP1427428B1 (de) | 2006-05-24 |
| DE60211721T2 (de) | 2007-05-24 |
| PT1427428E (pt) | 2006-10-31 |
| DE60211721D1 (de) | 2006-06-29 |
| CA2460098A1 (en) | 2003-03-27 |
| DK1427428T3 (da) | 2006-09-25 |
| EP1427428A2 (de) | 2004-06-16 |
| WO2003024419A3 (en) | 2003-09-18 |
| WO2003024419B1 (en) | 2003-10-30 |
| AU2002325739A1 (en) | 2003-04-01 |
| WO2003024419A2 (en) | 2003-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll‐like receptor 2 | |
| Heilig et al. | Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD | |
| Tian et al. | Gingival mesenchymal stem cell‐derived exosomes are immunosuppressive in preventing collagen‐induced arthritis | |
| Qin et al. | Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer | |
| Nova et al. | Alveolar-capillary membrane-related pulmonary cells as a target in endotoxin-induced acute lung injury | |
| Romano et al. | Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells | |
| Mizoguchi et al. | Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation | |
| Garzón-Tituaña et al. | Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis | |
| Tamura et al. | Paracellular barrier and channel functions of TJ claudins in organizing biological systems: advances in the field of barriology revealed in knockout mice | |
| Liszewski et al. | Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation | |
| Edgerton et al. | IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice | |
| Lo Monaco et al. | Therapeutic potential of dental pulp stem cells and leukocyte-and platelet-rich fibrin for osteoarthritis | |
| Campos-Mora et al. | CD4+ Foxp3+ T regulatory cells promote transplantation tolerance by modulating effector CD4+ T cells in a neuropilin-1-dependent manner | |
| Huang et al. | Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway | |
| DE60211721D1 (de) | Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung | |
| Itoh et al. | IL-17 contributes to the development of chronic rejection in a murine heart transplant model | |
| Kim et al. | 14-3-3ζ: A suppressor of inflammatory arthritis | |
| Lee et al. | The selenoprotein MsrB1 instructs dendritic cells to induce T-helper 1 immune responses | |
| Rima et al. | Vipers of the Middle East: a rich source of bioactive molecules | |
| Park et al. | IL-33 changes CD25hi Tregs to Th17 cells through a dendritic cell-mediated pathway | |
| Simpson et al. | Plasmacytoid dendritic cells respond directly to apoptotic cells by secreting immune regulatory IL-10 or IFN-α | |
| Kumar | Cytotoxic T cells: kill, memorize, and mask to maintain immune homeostasis | |
| Adib et al. | In vitro modulation of macrophage inflammatory and pro-repair properties essential for wound healing by calcium and calcium-alginate dressings | |
| Sun et al. | Chensinin-1b alleviates DSS-induced inflammatory bowel disease by inducing macrophage switching from the M1 to the M2 phenotype | |
| Wicki et al. | Loss of BID delays FASL-induced cell death of mouse neutrophils and aggravates DSS-induced weight loss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1427428 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |